The substitution at position 8, where alanine is replaced by 2-aminoisobutyric acid, is the protease-resistance change
With the growing rates of obesity and diabetes, glucagon-like peptide-1 (GLP-1)-based therapies have emerged as powerful tools to tackle these conditions (16)
Encouraging results have also been reported with mazdutide (LY3305677) in terms of BW, blood pressure (BP), glucose and lipid lowering 47 , and efinopegdutide (MK-6024) in terms of liver fat content in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) with or without T2D 48
The American Diabetes Association notes that GH excess (as seen in acromegaly) causes frank diabetes in approximately 20-30% of patients [11], a caution that extends by mechanism to prolonged secretagogue use
Among users who post about side effects, the most-discussed run nausea, fatigue, GI-other, anxiety, diarrhea, constipation, menstrual changes, and reflux/burps, in that order